Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ESI-TBVI

Financiado

Cerrado

Establishment Strategy and Initial activities of the TuBerculosis Vaccine Initi...

Establishment Strategy and Initial activities of the TuBerculosis Vaccine Initiative Coordination of European efforts with global research initiatives The goal is to establish a TB Vaccine Initiative (TBVI) as a private public partnership. It will ensure an appropriate linkage between EC supported projects and global initiatives aiming at the development of new TB vaccines. TBVI... ver más

30/04/2010

IDL

520K€

Presupuesto del proyecto: 520K€

Líder del proyecto

ID-LELYSTAD, INSTITUUT VOOR DIERHOUDERIJ EN D... No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 5 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2010-04-30 No tenemos la información de la convocatoria

0% 83% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

5 Participantes

IDL

101.26K€ | Lider

SSI

N.D. | Participante

TBVI

N.D. | Participante

LSHTM

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

NEWTBVAC Discovery and preclinical development of new generation tube... 19M€ Cerrado

TBVAC2020 TBVAC2020 Advancing novel and promising TB vaccine candidat... 25M€ Cerrado

IPROVE Innovation Partnership for a Roadmap on Vaccines in Europe 670K€ Cerrado

DESARROLLO DE UNA VACUNA PARA EL TRATAMIENTO... DESARROLLO DE UNA VACUNA PARA EL TRATAMIENTO INMUNO TERAPÉUT... 1M€ Cerrado

INYVAX Optimisation of the development of Poverty Related Diseases... 1M€ Cerrado

EAVI2020 European AIDS Vaccine Initiative 2020 24M€ Cerrado

Líder del proyecto

ID-LELYSTAD, INSTITUUT VOOR DIERHOUDERIJ EN D... No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 520K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The goal is to establish a TB Vaccine Initiative (TBVI) as a private public partnership. It will ensure an appropriate linkage between EC supported projects and global initiatives aiming at the development of new TB vaccines. TBVI will be established as a legal entity stemming from TBVAC, the FP6 EC supported project on TB vaccines, that has proven remarkably successful. TBVI will aim to facilitate the completion of vaccine development by their respective developers, and will not claim the ownership of any new products nor IP rights. Specific objectives of TBVI will be: a-To establish a working group to ensure coordination of activities related to TB vaccine development. It will comprise leaders of AERAS, BMGF, Stop TB (vaccines), TBVI and related EC projects. Regular meetings will be organized to define approaches regarding pre-clinical and clinical development. b- To advocate efforts towards the completion of TB vaccine development, including the mobilization of additional resources. c- To sustain and expand project management activities in the area of TB vaccine development . This will include advisory activities conducted through vaccine-specific product development teams (PDT) and management of specific European projects. The executive operational office will be based in ID-Lelystad (NL). A steering board comprising European scientists, with expertise in vaccine development, will meet on a monthly basis to decide on proposed and ongoing activities, development strategies and selection of new projects. A board of stakeholders/interested parties will review the overall activities and budget, and facilitate the mobilization of resources for TB vaccine development.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores